Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Niobium is a chemical element (symbol Nb) and a transition metal that has been investigated for medical applications due to its biocompatibility and inertness. It is primarily used in the medical field to create safe and durable implants such as bone plates, screws, dental prosthetics, and coronary stents because it does not trigger immune responses or cause harm to body tissues[1][4]. Niobium has also been studied in clinical trials for the treatment of obesity and overweight[2][3]. Its mechanism of action as a drug is not well defined; rather, its value lies in its physical properties—such as corrosion resistance and hypoallergenic nature—which make it suitable for use in biomedical devices. There are no approved pharmaceutical indications for niobium as an active drug substance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on niobium.